AGP Picks
View all

Science Times Observer: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Times Observer.

Press releases published on October 20, 2026

Cerebras Systems Announces Date of Third-Quarter 2026 Financial Results
Lesaka Webcast and Conference Call to Review First Quarter 2027 Results
Douglas Dynamics Announces Third Quarter 2026 Earnings Release and Conference Call
Rapid7 Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
BNB Standard Corporation to Ring the Nasdaq Opening Bell on October 26 to Celebrate Its New Name and Leadership
Acquisition of Own Shares
Inkoop van eigen aandelen
Inhibikase Therapeutics Appoints Scott Wasserman to Board of Directors
INLIF LIMITED Announces Closing of US$3.75 Million Registered Direct Offering
Alice & Bob shares first results from France's PROQCIMA quantum programme
Callings.ai Launches Outplacement 2.0 at HR Tech 2026, Turning Employee Exits Into Lasting Talent Relationships
Money Management International Issues First Athlete $martPlay White Paper on College Athletes and Money
Fortrea schließt die Übernahme des Geschäftsbereichs „Early Phase Services“ von Worldwide Clinical Trials ab
Fortrea completa la adquisición de la división de servicios de fase temprana de Worldwide Clinical Trials
Fortrea finalise l’acquisition de la division Early Phase Services de Worldwide Clinical Trials
Fortrea משלימה את רכישת חטיבת שירותי השלב המוקדם מ- Worldwide Clinical Trials
Fortrea Rampungkan Akuisisi Divisi Early Phase Services dari Worldwide Clinical Trials
フォートリア、ワールドワイド・クリニカル・トライアルズから早期段階サービス部門の買収を完了
포트리아, 월드와이드 클리니컬 트라이얼스의 초기 임상 서비스 사업부 인수 완료
Fortrea Melengkapkan Pemerolehan Bahagian Early Phase Services daripada Worldwide Clinical Trials

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Science Times Observer

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.